Cargando…
Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study
Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495847/ https://www.ncbi.nlm.nih.gov/pubmed/28110415 http://dx.doi.org/10.1007/s10096-017-2907-x |
_version_ | 1783247863611916288 |
---|---|
author | Paulsson, M. Granrot, A. Ahl, J. Tham, J. Resman, F. Riesbeck, K. Månsson, F. |
author_facet | Paulsson, M. Granrot, A. Ahl, J. Tham, J. Resman, F. Riesbeck, K. Månsson, F. |
author_sort | Paulsson, M. |
collection | PubMed |
description | Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality and is superior compared to monotherapy, we investigated the effect of antimicrobial treatment regimens on 30-day mortality in a cohort with Pseudomonas aeruginosa bacteraemia. All cases of P. aeruginosa bacteraemia (n = 292) in southwest Skåne County, Sweden (years 2005–2010, adult population 361,112) and the whole county (2011–2012, 966,130) were identified. Available medical and microbiological records for persons aged 18 years or more were reviewed (n = 235). Antimicrobial therapy was defined as empiric at admission or definitive after culture results and was correlated to 30-day mortality in a multivariate regression model. The incidence and mortality rates were 8.0 per 100,000 adults and 22.9% (67/292), respectively. As expected, multiple comorbidities and high age were associated with mortality. Adequate empiric or definitive antipseudomonal treatment was associated with lower mortality than other antimicrobial alternatives (empiric p = 0.02, adj. p = 0.03; definitive p < 0.001, adj. p = 0.007). No difference in mortality was seen between empiric antipseudomonal monotherapy or empiric combination therapy. However, definitive combination therapy including ciprofloxacin correlated to lower mortality than monotherapy (p = 0.006, adj. p = 0.003), whereas combinations including tobramycin did not. Our results underline the importance of adequate antipseudomonal treatment. These data also suggest that P. aeruginosa bacteraemia should be treated with an antimicrobial combination including ciprofloxacin when susceptible. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10096-017-2907-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5495847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-54958472017-07-18 Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study Paulsson, M. Granrot, A. Ahl, J. Tham, J. Resman, F. Riesbeck, K. Månsson, F. Eur J Clin Microbiol Infect Dis Original Article Ineffective antimicrobial therapy of Pseudomonas aeruginosa bacteraemia increases mortality. Recent studies have proposed the use of antimicrobial combination therapy composed of a beta-lactam with either ciprofloxacin or tobramycin. To determine if combination therapy correlates to lower mortality and is superior compared to monotherapy, we investigated the effect of antimicrobial treatment regimens on 30-day mortality in a cohort with Pseudomonas aeruginosa bacteraemia. All cases of P. aeruginosa bacteraemia (n = 292) in southwest Skåne County, Sweden (years 2005–2010, adult population 361,112) and the whole county (2011–2012, 966,130) were identified. Available medical and microbiological records for persons aged 18 years or more were reviewed (n = 235). Antimicrobial therapy was defined as empiric at admission or definitive after culture results and was correlated to 30-day mortality in a multivariate regression model. The incidence and mortality rates were 8.0 per 100,000 adults and 22.9% (67/292), respectively. As expected, multiple comorbidities and high age were associated with mortality. Adequate empiric or definitive antipseudomonal treatment was associated with lower mortality than other antimicrobial alternatives (empiric p = 0.02, adj. p = 0.03; definitive p < 0.001, adj. p = 0.007). No difference in mortality was seen between empiric antipseudomonal monotherapy or empiric combination therapy. However, definitive combination therapy including ciprofloxacin correlated to lower mortality than monotherapy (p = 0.006, adj. p = 0.003), whereas combinations including tobramycin did not. Our results underline the importance of adequate antipseudomonal treatment. These data also suggest that P. aeruginosa bacteraemia should be treated with an antimicrobial combination including ciprofloxacin when susceptible. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10096-017-2907-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-01-21 2017 /pmc/articles/PMC5495847/ /pubmed/28110415 http://dx.doi.org/10.1007/s10096-017-2907-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Paulsson, M. Granrot, A. Ahl, J. Tham, J. Resman, F. Riesbeck, K. Månsson, F. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
title | Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
title_full | Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
title_fullStr | Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
title_full_unstemmed | Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
title_short | Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
title_sort | antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of pseudomonas aeruginosa bacteraemia: a retrospective cohort study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495847/ https://www.ncbi.nlm.nih.gov/pubmed/28110415 http://dx.doi.org/10.1007/s10096-017-2907-x |
work_keys_str_mv | AT paulssonm antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy AT granrota antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy AT ahlj antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy AT thamj antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy AT resmanf antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy AT riesbeckk antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy AT manssonf antimicrobialcombinationtreatmentincludingciprofloxacindecreasedthemortalityrateofpseudomonasaeruginosabacteraemiaaretrospectivecohortstudy |